Response: Platelets do not generate activated factor XII—how inappropriate experimental models have led to misleading conclusions by Niklas Boknäs, Lars.

Slides:

Advertisements

Similar presentations

Potential of the Factor Xa Inhibitor Rivaroxaban for the Anticoagulation Management of Patients with Heparin-Induced Thrombocytopenia Jeanine M. Walenga,

Advertisements

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.

TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain by Natalia Reglińska-Matveyev, Helena M. Andersson, Suely M. Rezende,

Activation of factor XI by products of prothrombin activation

by Wei Zhang, and Robert W. Colman

by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and

Dasatinib suppresses in vitro natural killer cell cytotoxicity

Activation of αIIbβ3 is a sufficient but also an imperative prerequisite for activation of α2β1 on platelets by Gerlinde R. Van de Walle, Anne Schoolmeester,

Tissue-Specific Expression of Functional Platelet Factor XI Is Independent of Plasma Factor XI Expression by Chang-jun Hu, Frank A. Baglia, David C.B.

Polyphosphates rock! A role in thrombosis?

High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors by Glaivy Batsuli, Wei Deng, John.

Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels by Carina J. M. van Schooten,

Intracoronary shear-related up-regulation of platelet P-selectin and platelet-monocyte aggregation despite the use of aspirin and clopidogrel by Andy S.

Next-generation leukemia immunotherapy

PRT , a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model by Michael P. Reilly, Uma Sinha,

Vessel wall BAMBI contributes to hemostasis and thrombus stability

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

Recombinant factor VIIa restores aggregation of αIIbβ3-deficient platelets via tissue factor–independent fibrin generation by Ton Lisman, Jelle Adelmeijer,

Effects of inflammatory cytokines on the release and cleavage of the endothelial cell–derived ultralarge von Willebrand factor multimers under flow by.

Novel Evidence of Expression and Activity of Ecto-Phospholipase C γ1 in Human T Lymphocytes by Sebastiano Miscia, Angela Di Baldassarre, Amelia Cataldi,

How I treat elderly patients with myeloma

Nonmyeloablative conditioning for relapsed follicular lymphoma

by Zhengyan Wang, Tina M. Leisner, and Leslie V. Parise

Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk by Alisa S. Wolberg, Dougald.

by Laurent O. Mosnier, Paula Buijtenhuijs, Pauline F. Marx, Joost C. M

by Wolfram Springer, Alexander von Ruecker, and Roswitha Dickerhoff

How we choose factor VIII to treat hemophilia

Anti–factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome by Mihály Józsi, Stefanie Strobel, Hans-Martin.

Serum amyloid A is an innate immune opsonin for Gram-negative bacteria

by Monica Galli, Luisa Ruggeri, and Tiziano Barbui

by James D. Cook, Carol H. Flowers, and Barry S. Skikne

Platelet Ca2+ responses coupled to glycoprotein VI and Toll-like receptors persist in the presence of endothelial-derived inhibitors: roles for secondary.

An In Vitro Model for Toxin-Mediated Vascular Leak Syndrome: Ricin Toxin A Chain Increases the Permeability of Human Endothelial Cell Monolayers by Alan.

by Cornelis van 't Veer, Neal J. Golden, and Kenneth G. Mann

by Matthew F. Whelihan, Vicentios Zachary, Thomas Orfeo, and Kenneth G

by Anne-lie Ståhl, Lisa Sartz, and Diana Karpman

Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of.

Apoptotic Vascular Endothelial Cells Become Procoagulant

Influenza virus H1N1 activates platelets through FcγRIIA signaling and thrombin generation by Eric Boilard, Guillaume Paré, Matthieu Rousseau, Nathalie.

Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase–signaling pathways by Katie.

by Andrew J. Gale, Mary J. Heeb, and John H. Griffin

Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw,

Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent.

by Jacques Himber, Louis Burcklen, and Beat Steiner

Anergy: the CLL cell limbo

Mechanism of factor VIIa–dependent coagulation in hemophilia blood

Rapid ubiquitination of Syk following GPVI activation in platelets

Diverging signaling events control the pathway of GPVI down-regulation in vivo by Tamer Rabie, David Varga-Szabo, Markus Bender, Rastislav Pozgaj, Francois.

by Eleanor J. Molloy, Amanda J. O'Neill, Julie J

In-depth PtdIns(3,4,5)P3 signalosome analysis identifies DAPP1 as a negative regulator of GPVI-driven platelet function by Tom N. Durrant, James L. Hutchinson,

Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis by Manasa K. Nayak, Nirav Dhanesha,

Inter-α inhibitor proteins maintain neutrophils in a resting state by regulating shape and reducing ROS production by Soe Soe Htwe, Hidenori Wake, Keyue.

A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant by Shauna L. French, Claudia Thalmann, Paul F.

Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors by Manu T. Kalathottukaren, A.

Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib by Alexander P. Bye, Amanda J. Unsworth,

Platelet HMGB1 is required for efficient bacterial clearance in intra-abdominal bacterial sepsis in mice by Hui Zhou, Meihong Deng, Yingjie Liu, Chenxuan.

by Christina U. Lorentz, Norah G

by Ludovic Durrieu, Alamelu Bharadwaj, and David M. Waisman

FcγRIIA and FcγRIIIB Are Required for Autoantibody-Induced Tissue Damage in Experimental Human Models of Bullous Pemphigoid Xinhua Yu, Karoline Holdorf,

Aggregation tracings of platelets lacking PLCβ2/β3.

Actin assembly in response to thrombin.

Erratum Kidney International Volume 61, Issue 4, (April 2002)

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Src kinases mediate TSP-1 inhibition of AC and PKA activity.

Volume 60, Issue 5, Pages (November 2001)

by Sarah M. Nordstrom, Brian A. Holliday, Brandon C. Sos, James W

Factor VIIa interaction with EPCR modulates the hemostatic effect of rFVIIa in hemophilia therapy: mode of its action by Shiva Keshava, Jagan Sundaram,

Reduced prothrombinase inhibition by tissue factor pathway inhibitor contributes to the factor V Leiden hypercoagulable state by Jeremy P. Wood, Lisa M.

A binding relationship with thrombin

by Fabian C. Verbij, Nicoletta Sorvillo, Paul H. P

Presentation transcript:

Response: Platelets do not generate activated factor XII—how inappropriate experimental models have led to misleading conclusions by Niklas Boknäs, Lars Faxälv, Jakob O. Ström, Pentti Tengvall, Elvar Theodorsson, Sofia Ramström, and Tomas L. Lindahl Blood Volume 124(10):1692-1694 September 4, 2014 ©2014 by American Society of Hematology

Contact activation in vitro. Contact activation in vitro. (A) Filtration with Minisart filters does not cause significant contact activation: FXIIa generation was measured before (control) and after filtration of plasma with the filters used in our Blood paper,1 and kaolin (100 μg/mL) was used as positive control (n = 4, ns, nonsignificant Student t test). (B) Amelung KC4 causes contact activation, leading to substantial thrombin generation: pooled citrated plasma samples with or without CTI corn trypsin inhibitor (CTI) were incubated for 20 minutes at 37°C in Amelung KC4, ReoRox4, or polypropylene (PP) tubes. FXIIa generation was measured as described previously1 with the fluorescent substrate present during incubation in the instrument. Bars represent FXIIa substrate fluorescence as percentage of the PP tubes (n = 8, background fluorescence of inhibitor/vehicle additions were compensated). Aliquots from incubated plasma were used for subsequent real-time thrombin generation measurements in the presence of 10 μM phospholipids. Curves represent means of 4 independent experiments. Niklas Boknäs et al. Blood 2014;124:1692-1694 ©2014 by American Society of Hematology